NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

57 hedge funds and large institutions have $55.8M invested in NeuBase Therapeutics, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 16 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+22
Holders Change %
+62.86%
% of All Funds
1.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
33
Increased
16
Reduced
4
Closed
11
Calls
$4.99M
Puts
$7.9M
Net Calls
-$2.92M
Net Calls Change
-$2.86M